Hideo Harigae Selected Research

Hideo Harigae Research Topics

Disease

21	Neoplasms (Cancer) 09/2022 - 12/2004
15	Lymphoma (Lymphomas) 01/2022 - 03/2002
14	Sideroblastic Anemia 01/2022 - 06/2003
13	Infections 08/2021 - 04/2004
11	X-linked sideroblastic anemia 01/2022 - 06/2003
11	Leukemia 01/2019 - 06/2004
9	Multiple Myeloma 01/2024 - 01/2009
9	Anemia 01/2018 - 06/2003
8	Inflammation (Inflammations) 01/2024 - 02/2016
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2023 - 01/2011
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 12/2005
8	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 08/2005
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2007
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2021 - 06/2002
6	Rheumatoid Arthritis 06/2022 - 06/2010
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2011
5	T-Cell Lymphoma (Lymphoma, T Cell) 04/2022 - 10/2006
5	Autoimmune Diseases (Autoimmune Disease) 05/2021 - 01/2013
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 04/2010
4	COVID-19 01/2024 - 01/2022
4	Pain (Aches) 12/2023 - 02/2009
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 10/2009
4	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2023 - 01/2015
4	Takayasu Arteritis (Arteritis, Takayasu's) 06/2022 - 11/2019
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2022 - 01/2009
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 09/2004
4	Disease Progression 11/2018 - 01/2009
4	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 03/2017 - 11/2011
4	Hematologic Diseases (Blood Diseases) 03/2014 - 10/2003
3	Pneumonia (Pneumonitis) 01/2024 - 04/2004
3	Fibrosis (Cirrhosis) 01/2024 - 01/2016
3	Aplastic Anemia (Anemia, Hypoplastic) 08/2023 - 05/2010
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2022 - 01/2018
3	Pathologic Complete Response 09/2022 - 07/2009
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2016
3	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022 - 01/2009
3	Acute Promyelocytic Leukemia 01/2022 - 07/2008
3	Exanthema (Rash) 01/2022 - 09/2004
3	Fever (Fevers) 01/2022 - 02/2009
3	Vasculitis (Vasculitides) 05/2021 - 07/2012
3	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 01/2016
3	Thrombotic Thrombocytopenic Purpura 01/2017 - 01/2009
3	Hepatitis B 01/2015 - 11/2013
3	Hemolytic Anemia 01/2013 - 01/2010
3	Collagen Diseases (Collagen Disease) 01/2013 - 01/2009
3	Philadelphia Chromosome 07/2011 - 09/2004
2	Thrombosis (Thrombus) 01/2024 - 08/2016
2	Hemolysis 12/2023 - 01/2010
2	Pancytopenia 08/2023 - 06/2003
2	Vasovagal Syncope 03/2023 - 01/2022
2	Hypersensitivity (Allergy) 03/2023 - 02/2009
2	Syncope (Fainting) 03/2023 - 01/2022
2	Iron Deficiencies 01/2023 - 01/2017
2	Large Granular Lymphocytic Leukemia 01/2023 - 01/2010
2	Eosinophilia 11/2022 - 01/2009
2	Cerebral Hemorrhage 11/2022 - 09/2020
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2022 - 10/2006

Drug/Important Bio-Agent (IBA)

13	Heme (Haem)IBA 01/2023 - 02/2002
11	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2003
11	IronIBA 01/2023 - 10/2008
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 04/2004
10	Rituximab (Mabthera)FDA Link 11/2022 - 07/2009
10	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 07/2009
10	EnzymesIBA 11/2019 - 01/2010
9	AntibodiesIBA 10/2023 - 06/2003
9	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 01/2009
9	AutoantibodiesIBA 01/2022 - 07/2009
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2003
6	Transcription Factors (Transcription Factor)IBA 10/2018 - 06/2004
6	CytokinesIBA 02/2016 - 11/2006
5	SteroidsIBA 08/2023 - 06/2003
5	Methotrexate (Mexate)FDA LinkGeneric 09/2022 - 04/2007
5	5-Aminolevulinate SynthetaseIBA 01/2022 - 06/2003
5	Tacrolimus (Prograf)FDA LinkGeneric 10/2020 - 04/2007
5	SulfurIBA 01/2019 - 10/2010
5	Imatinib Mesylate (Gleevec)FDA Link 12/2015 - 09/2004
4	tisagenlecleucelIBA 01/2024 - 01/2022
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2022 - 01/2018
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 11/2013
4	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 12/2005
4	Immunoglobulin G (IgG)IBA 11/2018 - 07/2012
4	Messenger RNA (mRNA)IBA 02/2014 - 06/2002
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2024 - 06/2022
3	VaccinesIBA 12/2023 - 01/2022
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2012
3	tocilizumab (atlizumab)FDA Link 06/2022 - 06/2010
3	CreatinineIBA 01/2021 - 01/2010
3	AutoantigensIBA 01/2020 - 01/2013
3	Bortezomib (Velcade)FDA Link 11/2018 - 04/2009
2	Plasminogen Activator Inhibitor 1IBA 01/2024 - 01/2023
2	Brentuximab VedotinIBA 09/2022 - 05/2020
2	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2015

Therapy/Procedure

37	Therapeutics 11/2022 - 06/2003
24	Drug Therapy (Chemotherapy) 01/2024 - 12/2004
14	Hematopoietic Stem Cell Transplantation 09/2022 - 09/2004
13	Transplantation 10/2023 - 04/2004
7	Stem Cell Transplantation 06/2022 - 04/2004
3	Aftercare (After-Treatment) 06/2013 - 04/2010
2	Plasmapheresis 08/2023 - 01/2009
2	Induction Chemotherapy 09/2022 - 01/2022